a public good project by the
Synthesis
Company
of California

© 2026

Qichao Bao | doi.page

0 works0 citations0 h-index

Qichao Bao

China Pharmaceutical University(CN)Medicina(PL)State Key Laboratory of Natural MedicineThe University of Texas Medical Branch at Galveston(US)

Publications by Year

Research Areas

Heat shock proteins research, Ubiquitin and proteasome pathways, Computational Drug Discovery Methods, Epigenetics and DNA Methylation, Cancer-related Molecular Pathways

Most-Cited Works

→ NRF2 promotes breast cancer cell proliferation and metastasis by increasing RhoA/ROCK pathway signal transduction(2016)122 cited
→ Small-molecule inhibitor targeting the Hsp90-Cdc37 protein-protein interaction in colorectal cancer(2019)100 cited
→ Discovery and Modification of in Vivo Active Nrf2 Activators with 1,2,4-Oxadiazole Core: Hits Identification and Structure–Activity Relationship Study(2015)48 cited
→ Optimization and biological evaluation of celastrol derivatives as Hsp90–Cdc37 interaction disruptors with improved druglike properties(2016)44 cited
→ Novel Tetrahydropyrido[4,3-d]pyrimidines as Potent Inhibitors of Chaperone Heat Shock Protein 90(2016)35 cited
→ Affinity-Based Fluorescence Polarization Assay for High-Throughput Screening of Prolyl Hydroxylase 2 Inhibitors(2015)28 cited

→ Novel Natural Product-like Caged Xanthones Bearing a Carbamate Moiety Exhibit Antitumor Potency and Anti-Angiogenesis Activity In vivo(2016)

27 cited

→ Discovery and identification of Cdc37-derived peptides targeting the Hsp90–Cdc37 protein–protein interaction(2015)24 cited

→ Novel 5-carboxy-8-HQ based histone demethylase JMJD2A inhibitors: Introduction of an additional carboxyl group at the C-2 position of quinoline(2015)21 cited

→ Discovery of 1H-Imidazo[4,5-b]pyridine Derivatives as Potent and Selective BET Inhibitors for the Management of Neuropathic Pain(2023)13 cited